港股異動 | 否認私有化計劃傳聞 ASM太平洋(0522.HK)午後仍直線拉昇漲超11%
格隆匯9月22日丨半導體設備製造商ASM太平洋(0522.HK)午後直線拉昇,現報89.2港元,大漲11.5%,暫成交1.6億港元,最新總市值364億港元。今日午間有媒體援引知情人士稱,ASM太平洋正與潛在投資者洽談私有化事宜。該公司目標是在上交所科創板重新上市,以獲得更高估值。該公司的母公司為荷蘭芯片製造商ASMI,持有香港子公司約25%的股份,知情人士表示,該公司支持這一提案,但不打算出售所持股份。不過,ASM太平洋否認了私有化計劃,ASMI並未立即回覆置評請求。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.